Alkermes
ALKS
#2133
Rank
A$13.30 B
Marketcap
A$79.81
Share price
4.26%
Change (1 day)
80.97%
Change (1 year)

Alkermes (ALKS) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : A$3.63 Billion

According to Alkermes's latest financial reports the company's total liabilities are A$3.63 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Alkermes - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$0.99 B4.99%
2024-12-31A$0.94 B-30.7%
2023-12-31A$1.37 B1.33%
2022-12-31A$1.35 B7.51%
2021-12-31A$1.25 B9.56%
2020-12-31A$1.14 B11.64%
2019-12-31A$1.02 B10.81%
2018-12-31A$0.92 B21.88%
2017-12-31A$0.76 B6.17%
2016-12-31A$0.71 B-3.51%
2015-12-31A$0.74 B16.48%
2014-12-31A$0.63 B
2013-03-31A$0.49 B-11.19%
2012-03-31A$0.56 B857.74%
2011-03-31A$58.47 M-47.72%
2010-03-31A$0.11 B-40.58%
2009-03-31A$0.18 B-50.6%
2008-03-31A$0.38 B-15.68%
2007-03-31A$0.45 B-28.14%
2006-03-31A$0.62 B45.19%
2005-03-31A$0.43 B68.16%
2004-03-31A$0.25 B-40.4%
2003-03-31A$0.43 B-8.01%
2002-03-31A$0.46 B-6.51%
2001-03-31A$0.50 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$173.45 B 4,675.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$115.34 B 3,075.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$169.84 B 4,576.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$92.04 B 2,434.19%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$96.17 B 2,548.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$96.54 B 2,558.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
Acorda Therapeutics
ACOR
A$0.38 B-89.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$46.08 B 1,169.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel